Live Breaking News & Updates on Newmediawire innovation pharmaceuticals

WAKEFIELD, MA, Aug. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company and minority stakeholder in BT BeaMed Technologies (“BeaMed”), is pleased to provide shareholders with an update on recent progress in the development of BeaMed’s groundbreaking StingRay Laser System (the “System”). BeaMed is a pioneering company dedicated to revolutionizing epilepsy and cancer surgery through laser-based innovat

Israel , United-states , Gil-shapira , Moshe-eshkol , Leo-ehrlich , Israel-institute-of-technology , Exchange-commission , Innovation-pharmaceuticals-inc , Rambam-health-care-campus , Massachusetts-institute-of-technology , Newmediawire-innovation-pharmaceuticals , Innovation-pharmaceuticals